
Telesis Bio Investor Relations Material
Latest events

Q2 2023
Telesis Bio
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Telesis Bio Inc
Access all reports
Telesis Bio Inc. is a synthetic biology company that provides automated solutions for DNA and RNA synthesis. Its core product, the BioXp system, is the world’s first fully automated gene synthesis platform, enabling researchers to rapidly design, build, and clone high-quality synthetic DNA and mRNA. Telesis Bio's technologies are widely used in various applications, including vaccine development, gene and cell therapy, precision medicine, and biologics drug discovery. Telesis Bio is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
DNAY
Country
🇺🇸 United States